These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35628049)

  • 1. Oral Tissue Involvement and Probable Factors in Post-COVID-19 Mucormycosis Patients: A Cross-Sectional Study.
    Chandwani N; Dabhekar S; Selvi K; Mohamed RN; Abullais SS; Moothedath M; Jadhav G; Chandwani J; Karobari MI; Pawar AM
    Healthcare (Basel); 2022 May; 10(5):. PubMed ID: 35628049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends of rhino-orbito-cerebral mucormycosis in COVID-19 patients: An observational study.
    Singh N; Singh S; Singh P; Mishra N; Sinha BP; Shrama AK
    J Family Med Prim Care; 2022 Dec; 11(12):7891-7896. PubMed ID: 36994064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and Covid Associated Mucormucormycosis-A Cross Sectional Study in Kilpauk Medical College.
    Pradeepkumar V
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.
    Urias-Barreras CM; Rodríguez-Archilla A; Canizalez-Roman A; Bastidas DA; León-Sicairos NM
    J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101615. PubMed ID: 37648209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset hyperglycaemia and prolonged systemic corticosteroids therapy in mild COVID-19 patients as major risk factors for invasive mucormycosis: a preliminary study.
    Khichar S; Samantaray S; Kumar D; Mobarsa V; Jain V; Sharma V; Soni K; Choudhury B; Goyal A; Shankar Meena D; Srinivasan S; Dutt N; Bhardwaj P; Agarwal A; Kumar Garg M; Misra S
    Curr Med Mycol; 2021 Sep; 7(3):22-28. PubMed ID: 35528622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study.
    Vijapur MM; Kattimani V; Varsha VK; Girish HC; Kamat M; Ram B
    J Oral Maxillofac Pathol; 2022; 26(2):147-155. PubMed ID: 35968169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, Clinical Profile, and Analysis of Risk Factors in COVID Associated Rhino-orbito-cerebral Mucormycosis Patients - An Observational Study.
    Jog K; Nazirudeen R; Eagappan S; Santharam RK; Sridhar S
    Indian J Endocrinol Metab; 2023; 27(6):519-523. PubMed ID: 38371190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
    Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
    Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Associated Mucormycosis.
    Tazeem S; Nagaraju A; Begum H; Tommi JA; Sudarshan Reddy L; Vijay Kumar M
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(4):1-9. PubMed ID: 37362123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, Demographic, and Oral Presentations of COVID-19 Associated Mucormycosis from a Tertiary Care Hospital in India: A Cross-Sectional Study.
    Somkuwar S; Vijayabharathi P; Galhotra V; Rao S; Nagarkar NM; Raghani M; Pathak VK; Mehta R
    J Maxillofac Oral Surg; 2023 Dec; 22(4):1130-1138. PubMed ID: 38105823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral manifestations, risk factors and management strategies of COVID-19 associated mucormycosis in tertiary care hospital.
    Goel P; Kumar J; Rai A; Shakti P; Chouksey G
    Indian J Dent Res; 2023; 34(2):155-158. PubMed ID: 37787203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre.
    Walia S; Bhaisare V; Rawat P; Kori N; Sharma M; Gupta N; Urdhwareshwar S; Thakur S; Arya N
    Indian J Ophthalmol; 2021 Dec; 69(12):3685-3689. PubMed ID: 34827023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: A retrospective observational study.
    Irfan A; Kamran AH; Ammar M; Rahman SU
    Health Sci Rep; 2023 Feb; 6(2):e1083. PubMed ID: 36761033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Mucormycosis with Various Clinical Parameters Among COVID-19 Patients: A Cross-Sectional Study.
    Jadhav H; Vishwakarma P; Thamke S; Pundkar S; Takle T; Khairnar M
    J Maxillofac Oral Surg; 2023 May; ():1-5. PubMed ID: 37362876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Cutaneous Mucormycosis Post-COVID-19: Case Series from a Tertiary Center.
    Abhirami B; Kumar P; Mishra DK; Yadav SP
    Indian J Dermatol; 2022; 67(2):206. PubMed ID: 36092197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.